NUVA
NuVasive Inc
Price:  
39.75 
USD
Volume:  
31,368,200.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NuVasive WACC - Weighted Average Cost of Capital

The WACC of NuVasive Inc (NUVA) is 6.9%.

The Cost of Equity of NuVasive Inc (NUVA) is 8.35%.
The Cost of Debt of NuVasive Inc (NUVA) is 4.55%.

Range Selected
Cost of equity 7.30% - 9.40% 8.35%
Tax rate 20.70% - 22.20% 21.45%
Cost of debt 4.00% - 5.10% 4.55%
WACC 6.1% - 7.8% 6.9%
WACC

NuVasive WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.75 0.81
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.40%
Tax rate 20.70% 22.20%
Debt/Equity ratio 0.43 0.43
Cost of debt 4.00% 5.10%
After-tax WACC 6.1% 7.8%
Selected WACC 6.9%

NuVasive's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for NuVasive:

cost_of_equity (8.35%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.75) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.